LL-K9-3

CAT: 0804-HY-156084-01Size: 1 mgDry Ice: NoHazardous: No
CAT#:0804-HY-156084-01Size:1 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
LL-K9-3 is a potent small-molecule degrader of CDK9-cyclin T1. LL-K9-3 has anti-proliferative and pro-apoptotic activities and suppresses downstream signaling of CDK9 and AR. Moreover, LL-K9-3 inhibits AR and Myc-driven oncogenic transcriptional programs[1].
CAS Number
[2809353-52-2]
UNSPSC
12352005
Target
Apoptosis; CDK; c-Myc; PROTACs
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; PROTAC
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ll-k9-3.html
Purity
99.2
Solubility
10 mM in DMSO
Smiles
O=S(CCNC(CO[C@H]1[C@@H](CC[C@H](C1)C)C(C)C)=O)(N2CCC(CC2)C(NC3=NC=C(SCC4=NC=C(C(C)(C)C)O4)S3)=O)=O
Molecular Formula
C31H49N5O6S3
Molecular Weight
683.95
References & Citations
[1]Li J, et al. Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer. J Med Chem. 2022 Aug 25;65 (16) :11034-11057.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported

Related Products

CatalogName
HY-P5729LL-25
HY-118132LL-Z1220
HY-136828LL-BM123α
HY-P4748LL-21
HY-115843LL-D05139β
HY-163944-01LL-K12-18
HY-P4128LL-37 SKE
HY-P10262LL-37-Cys
HY-120349LL-Z1640-4
HY-109963-01PR5-LL-CM01

Alternative Products

CatalogName
T83936LL-K9-3
sc-100738FBL18 (LL-3)
M40982-01K9
32-1398-10K9 IL 3 Recombinant Protein
MBS488749-01Anti-CD106 [B-K9 (C106-K9)]
PT-A04946-01SCF k9
PT-A01169-01CST3 k9
cyt-722-01k9 IL3
OAAV00952-200UGCD106 Recombinant Antibody [B-K9 (C106-K9) ]
068-24K9-HECI / K9-Hylarana erythrae Chymotrpsin Inhibitor

Popular Products